Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jacobsson

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
Annals of the Rheumatic Diseases|December 17, 2014
MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16M Østergaard, L T H Jacobsson, C Schaufelberger, et al.
Rheumatology (Oxford, England)|July 30, 2024
Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritisMonica Leu Agelii, Outi Sareila, Erik Lönnblom, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Arthritis Research & Therapy|November 10, 2005
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritisCarl Turesson, Daniel J Schaid, Cornelia M Weyand, et al.
Annals of the Rheumatic Diseases|April 19, 2017
The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohortZineb Ez-Zaitouni, Miranda van Lunteren, Pauline A C Bakker, et al.
Annals of the Rheumatic Diseases|July 15, 2019
Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort studyManouk de Hooge, Floris A van Gaalen, Thomas Renson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2023
Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid ArthritisErik Lönnblom, Monica Leu Agelii, Outi Sareila, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid ArthritisJosephine A M P Amkreutz, Emma C de Moel, Lisa Theander, et al.
Rheumatology (Oxford, England)|December 28, 2020
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)|June 28, 2020
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort studyRebekka Lund Hansen, Tanja Schoedt Jørgensen, Lene Dreyer, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
Annals of the Rheumatic Diseases|December 17, 2014
MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16M Østergaard, L T H Jacobsson, C Schaufelberger, et al.
Rheumatology (Oxford, England)|July 30, 2024
Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritisMonica Leu Agelii, Outi Sareila, Erik Lönnblom, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Arthritis Research & Therapy|November 10, 2005
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritisCarl Turesson, Daniel J Schaid, Cornelia M Weyand, et al.
Annals of the Rheumatic Diseases|April 19, 2017
The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohortZineb Ez-Zaitouni, Miranda van Lunteren, Pauline A C Bakker, et al.
Annals of the Rheumatic Diseases|July 15, 2019
Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort studyManouk de Hooge, Floris A van Gaalen, Thomas Renson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2023
Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid ArthritisErik Lönnblom, Monica Leu Agelii, Outi Sareila, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid ArthritisJosephine A M P Amkreutz, Emma C de Moel, Lisa Theander, et al.
Rheumatology (Oxford, England)|December 28, 2020
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)|June 28, 2020
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort studyRebekka Lund Hansen, Tanja Schoedt Jørgensen, Lene Dreyer, et al.
Pageof 33